Idiopathic Thrombocytopenic Purpura Therapeutics Market to Surge with 5.0% CAGR, Anticipated Valuation Exceeds US$0.92 Billion by 2030 | Persistence Market Research New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview: The global Idiopathic Thrombocytopenic Purpura Therapeutics market is forecast to expand at a CAGR of 5.0% and thereby...

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market To Reach USD 783 Million By 2026 | Reports And Data New york, Nov. 18, 2019 (GLOBE NEWSWIRE) -- High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favorable research funding...